no surgery-related risks
single session treatment
no scar
THE ULTIMATE TREATMENT FOR THYROID NODULES AND BREAST FIBROADENOMA
ECHOPULSE® is the first robotic and 100% non-invasive solution for echotherapy treatment (High-Intensity Focused Ultrasound HIFU) of thyroid nodules and breast fibroadenoma. The therapeutic ultrasound is combined with a standard ultrasound beam to control the accuracy of the treatment. It can be operated by a single person in a nonsurgical environment. It leaves no scars and maintains the thyroid function and the integrity of the breast tissue.
ECHOPULSE RESULTS FOR THYROID NODULES
ECHOPULSE® echotherapy targets the nodule through thermoablation. The robot’s treatment head combines a therapeutic ultrasound probe with a linear one: The therapeutic ultrasound probe delivers the HIFU (High-Intensity Focused Ultrasound) beam and focusses it to concentrated the thermal energy to the target. The linear probe allows real-time image visualization for a precise energy deposit.
CHOTHERAPY RESULTS FOR FIBROADENOMA
Volume reductions of fibroadenoma after ECHOPULSE treatment can be expected to be around 70% after 12 months. Continued decrease in volume has been observed after this period.
HOW ECHOTHERAPY WORKS
ECHOPULSE® echotherapy targets the nodule through thermoablation. The robot’s treatment head combines a therapeutic ultrasound probe with a linear one: The therapeutic ultrasound probe delivers the HIFU (High-Intensity Focused Ultrasound) beam and focusses it to concentrated the thermal energy to the target. The linear probe allows real-time image visualization for a precise energy deposit.